Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials
about
A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery.Breast Cancer Clinical Trials: Past Half Century Moving Forward Advancing Patient Outcomes.Critical decision-making in radiotherapy for early stage breast cancer in a neo-adjuvant treatment era.Interim heterogeneity changes measured using entropy texture features on T2-weighted MRI at 3.0 T are associated with pathological response to neoadjuvant chemotherapy in primary breast cancer.Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy.Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials.Is Breast Surgery Necessary for Breast Carcinoma in Complete Remission Following Neoadjuvant Chemotherapy?Is Mastectomy Oncologically Safer than Breast-Conserving Treatment in Early Breast Cancer?ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy.Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy
P2860
Q38761471-2365D8C7-A52C-4DA9-B0AC-46E32BBAA1C9Q38830282-D5C47602-8DAE-4FF0-A449-DC08A46AD722Q38882550-FBB002CB-F45B-42B0-B4BD-B20CB502CBAEQ39173261-A1D95187-C9FC-45E5-9551-929D90220650Q42374260-2DBE5E36-EA25-4008-8FF4-D97987D1A35FQ47838863-3124FF1D-8DA7-4C31-911F-F36834F351FAQ48611302-8C38CC77-E357-429A-9273-D4EFC46F983BQ49634019-1EEC0EA1-9951-4C0F-9E28-AF2CA716E4D7Q49885178-BC30F26B-2B21-4930-9214-EF4D8A0A5EB4Q55013294-3719CB63-6C6C-4274-9022-B97D4B12AF8FQ55048928-07588BD6-381A-41B0-97D4-ACF43C8B8601Q57495769-9C0F7C10-0313-40F1-8B20-091CF3FC4A48
P2860
Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Selective elimination of breas ...... perspective and current trials
@ast
Selective elimination of breas ...... perspective and current trials
@en
Selective elimination of breas ...... perspective and current trials
@nl
type
label
Selective elimination of breas ...... perspective and current trials
@ast
Selective elimination of breas ...... perspective and current trials
@en
Selective elimination of breas ...... perspective and current trials
@nl
prefLabel
Selective elimination of breas ...... perspective and current trials
@ast
Selective elimination of breas ...... perspective and current trials
@en
Selective elimination of breas ...... perspective and current trials
@nl
P2860
P1476
Selective elimination of breas ...... perspective and current trials
@en
P2093
Henry M. Kuerer
Raquel F. D. van la Parra
P2860
P2888
P356
10.1186/S13058-016-0684-6
P407
P5008
P577
2016-03-08T00:00:00Z
P5875
P6179
1039446780